跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 27 条关于
“NFKB”
全部
27
临床试验
12
药物
2
机构
0
资讯
13
2年前
FDA Authorizes Phase 2 Trial of Bezisterim for Neurological Symptoms of Long COVID
去年
Novel Fenugreek-Based Nanoparticles Show Promise in Enhancing Diabetes Drug Delivery
2年前
FDA Approves Digital Therapeutic for GAD, Updated Novavax COVID-19 Vaccine, and New Insulin Patch Pump
去年
Gene Therapy for Osteoarthritis Shows Promising Results in Phase 1 Trial
去年
Opus Genetics Gains FDA Agreement for Phase 3 Trial of APX3330 in Diabetic Retinopathy
去年
Phase 2 Trial Evaluates Host-Directed Therapies for Rifampicin-Resistant Tuberculosis
去年
NFKB1 Haplotype Predicts Improved Response to Ropeginterferon Alfa-2b in PV and ET
去年
cGAS-STING Pathway Shows Dual Role in Breast Cancer Immunotherapy Response
去年
Pharming Group Initiates Phase II Trial of Leniolisib for Primary Immunodeficiencies
上个月
Thymulin Restrains Age-Associated Myeloid Inflammation and Enhances Cancer Immunotherapy in Preclinical Models
第 1 页,共 2 页
上一页
下一页